Phase II trial to investigate sonepcizumab in patients with cancer (neuroblastoma or prostate cancer).

Trial Profile

Phase II trial to investigate sonepcizumab in patients with cancer (neuroblastoma or prostate cancer).

Planning
Phase of Trial: Phase II

Latest Information Update: 06 Aug 2010

At a glance

  • Drugs Sonepcizumab (Primary)
  • Indications Neuroblastoma; Prostate cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Aug 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top